What's on the web on your pursuit, hobbies, interests and worries

MetabolicDiseases news

Will Updated Givosiran Data Stabilize Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)?

FDA Headlines - Nov 11, 2018
Its pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, and hepatic infectious diseases. The company's clinical development programs include Patisiran, which is in Phase III clinical trial for the ...

Disruption in time projection and non-adherence to long-term therapies

Dove Medical Press - Nov 8, 2018
1Department for Endocrinology, Diabetes and Metabolic Diseases, Avicenne Hospital, APHP, Bobigny, France; 2EA 3412, Health Education and Practices Laboratory (LEPS), Paris 13 University, Sorbonne Paris Cité, Bobigny, France; 3Clinical Research Unit ...

Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU Management. PKU GOLIKE ...

Associated Press (press release) (blog) - Nov 6, 2018
The paper, by four renowned experts in the field of inherited metabolic diseases (Anita MacDonald, Rani H. Singh, Júlio C. Rocha and Francjan J. van Spronsen), highlights for the first time the expected important benefits for PKU patients of an amino ...

Metabolic Diseases - premium items on eBay

NEW Inborn Metabolic Diseases: Diagnosis and Treatment


A Clinical Guide to Inherited Metabolic Diseases


NEW Inherited Metabolic Diseases: A Clinical Approach


>> Go to all great Metabolic Diseases deals on eBay

Metabolic Diseases pictures on the web

>> Show

Metabolic Diseases videos

Metabolic Diseases

Learn more about Celerion's approach for assessing the safety, pharmacokinetics and pharmacodynamics of new drug candidates designed to treat ...

Dr. Mercola on How to Effectively Prevent Metabolic Diseases

http://nutrientpower.com/?utm_source=youtube&utm_medium=video&utm_campaign=Content_DrMercolaTalk Dr. Joseph Mercola shares his insights on how to ...

Wyatt Yue: The genetics of metabolic diseases

METABOLIC AND RARE DISEASES Professor Wyatt Yue explores how genetic defects lead to disease at the molecular level, by determining 3D structures and ...

Using Microbiomes to Address Gastrointestinal and Metabolic Diseases

Second Genome's CEO @karimdabbagh explains how his company plans to translate microbiome science into the development of therapeutics.

Gut Flora - a Newly Recognized Participant in Complex Metabolic Diseases

Title: Gut Flora - a Newly Recognized Participant in Complex Metabolic Diseases Speaker: Stanley Hazen, MD, PhD Date: May 8, 2013 Location: campus, Case ...